Chemical Vapor Deposition Market Projected To Be Worth USD 48.01 Billion By 2025

The global chemical vapor deposition (CVD) market is expected to reach USD 48.01 billion by 2025, according to a new report by Grand View Research, Inc. Globally increasing demand from semiconductor industry has been a major factor driving industry growth. Also, growing consciousness regarding the benefits of these products along with consumer preference for modern and durable electronic devices has resulted in increased utilization CVD coatings in various applications.

CVD technology is employed for producing high-performance solid materials mainly to manufacture thin films for the semiconductor industry. In this process, the wafer/substrate comes in contact with a volatile precursor that reacts to form different types of deposits such as pyrolytic coatings, also referred to as hard coatings.

CVD coatings are generally deposited at higher temperatures and exhibit strong adhesion to glass surfaces. The volatile precursors for the process include halides (TiCl4, TaCl5, WF6), hydrides (SiH4, GeH4, and ammonia), metal organic compounds (metal alkyls/alkoxides/ dialylamides/diketonates/carbonyls), and others (ligands and complexes).

In the current scenario, industry players are focusing on developing processes for hybrid thin inorganic-organic deposition films to lower the production costs, thereby driving the semiconductor industry. This trend has led to increased and tighter supply of titanium compounds in compliance with environmental norms.

CVD equipment was the largest category in 2016 and is expected to maintain a relatively average growth rate over the forecast period owing to good quality of deposition films obtained from the equipment. CVD services segment is the fastest growing chemical vapor deposition segment owing to technological advancements in technologies such as plasma enhanced process, hot-wire and combustion based.

To Request A Sample Copy Or View Summary Of This Report
http://www.grandviewresearch.com/industry-analysis/chemical-vapor-deposition-cvd-market

Further key findings from the report suggest:

·       The global CVD market was valued at 20.8 billion in 2016 and is expected to grow at a CAGR of 9.8% from 2017 to 2025

·       In application segment, microelectronics was the largest consumption center in 2016 and is estimated to reach a net worth exceeding USD 17.90 billion by 2025

·       The Asia Pacific chemical vapor deposition market was the largest in 2016 and is anticipated to follow the same trend over the forecast period, owing to number of developments from end-use industries across major economies

·       The technology demand in the solar products (PV modules and solar cells) segment was valued over USD 390 million in 2016

·       These technologies are classified on the basis of operating pressure, physical characteristics of vapor and plasma enhanced chemical vapor deposition

·       Key players including Veeco Instruments, Inc., Ulvac, Inc., IHI Corporation, Applied Materials Inc. Tokyo Electron Limited and Adeka Corporationdominates the global market in 2016 with major market share.

Grand View Research has segmented the global Chemical Vapor Deposition (CVD) market on the basis of equipment & services, application and region:

Equipment & Services Outlook (Revenue, USD Million, 2014 - 2025)

·         CVD Equipment

·         CVD Materials

·         CVD Services

Application Outlook (Revenue, USD Million, 2014 - 2025)

·         Microelectronics

·         Data Storage

·         Solar Products

·         Cutting Tools

·         Medical Equipment

·         Others

Regional Outlook (Revenue, USD Million, 2014 - 2025)

·         North America

o    U.S.

·         Europe

o    Germany

o    U.K.

o    France

·         Asia Pacific

o    China

o    India

o    Japan

·         Central & South America  

·         Middle East & Africa 

Access Press Release of Chemical Vapor Deposition Market@ https://www.grandviewresearch.com/press-release/global-chemical-vapor-deposition-cvd-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Transcatheter Heart Valve Market Projected to Be Worth $8.6 Billion by 2024

The global transcatheter heart valve market is anticipated to reach a value of USD 8.62 billion by 2024, according to a new report by Grand View Research, Inc. The market is currently under-penetrated as these products are approved only for geriatric patients who cannot undergo normal valve surgeries. Growth drivers such as increasing prevalence of chronic cardiovascular diseases, increasing economic development, improvement in reimbursement scenario, and faster adoption of new technologies are expected to significantly improve the usage rates over the forecast period.

The transcatheter heart valve market is evolving rapidly due to the continuous investments in R&D by the key market players such as Edwards Life Sciences, Medtronic, St. Jude, and Boston Scientific. The technologically advanced products such as the SAPIEN 3 transcatheter heart valve and the TRINITY Valve are designed to reduce the surgical complications and improve patient compliance. For instance, the TRINITY TAVI system enables easy retrieval and repositioning of the device, without compromising on patient safety and treatment outcomes.

Furthermore, the market is expected to experience strong tailwinds on account of growing investor interest, lucrative product pipeline, faster regulatory approvals, and high competition to acquire potential start-ups. For example, some of the notable investments in the market include the USD 37 million funding of Venus MedTech by Goldman Sachs. In line with the market trends, the other market participants such as Boston Scientific, Edward Life Sciences, and Medtronic have also increased their investments to develop new products for management of mitral valve regurgitation and tricuspid valve replacements.

Access Research Report of Transcatheter Heart Valve Market @ www.grandviewresearch.com/industry-analysis/transcatheter-valve-market

Further Key Findings from the Study Suggest:

·       Aortic stenosis is the most prevalent valve disease, and if untreated it can lead to death. In 2015, transcatheter aortic valve segment accounted for the maximum revenue of over USD 1.6 billion and is expected to retain its dominant share over the forecast period.

·       However, the transcatheter mitral valve segment is expected to emerge as the fastest growing with a CAGR of 23% over the forecast period. Increasing number of elderly patients with mitral regurgitation and growing demand for technologically advanced transcatheter valve devices are expected to drive the usage of transcatheter mitral valves over the forecast period.

·       In 2015, the self-expanded transcatheter accounted for the largest market share of 65%. These catheters are most commonly used and, currently, most of the products that are available in the market are based on this technology. However, balloon expanded transcatheters are expected to have the fastest CAGR of 16.8% over the forecast period.

·       North America held the maximum share of nearly49% in 2015. A combination of different factors such as the presence of large target population, high disposable income, strong reimbursement framework, contribute toward the high revenue generated in this region.

·       Asia Pacific is anticipated to register the fastest CAGR of 17.8% over the forecast period. Increasing disease burden, improvement in clinical trial regulations, growing preference for advanced medical technologies, increase in medical tourism, and special incentives for investments in healthcare sector are expected to strongly favor the growth in this region.

·       Some key market players Boston Scientific Corporation, Bracco Group, Braile Biomedica, Direct Flow Medical, Edwards Lifesciences, JenaValve, St. Jude Medical, Symetis. ValveXchange, Edwards Lifesciences, and Medtronic are the early movers in this market have captured significant market share in the North America, Europe, and the Asia Pacific region.

Grand View Research has segmented the transcatheter heart valve market by application, technology and region:

Transcatheter Heart Valve Market Application Outlook (Market revenue in USD Million, 2013 - 2024)

·         Transcatheter aortic valve

·         Transcatheter pulmonary valve

·         Transcatheter mitral valve

Transcatheter Heart Valve Market Technology Outlook (Market revenue in USD Million, 2013 - 2024)

·         Balloon expanded transcatheter valve

·         Self-expanded transcatheter valve

Transcatheter Heart Valve Market Regional Outlook, (Market Revenue in USD Million, 2013 - 2024)

·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    UK

·         Asia Pacific

o    Japan

o    China

·         Latin America

o    Brazil

o    Mexico

·         MEA

o    South Africa

Access Press Release of Transcatheter Heart Valve Market@ www.grandviewresearch.com/press-release/global-transcatheter-valve-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research    reports, customized research reports, and consulting services. To help clients make informed business    decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com

Cancer Biomarkers Market is Poised to Exhibit A Moderate 14.3%CAGR through 2025

The global cancer biomarkers market is expected to reach a value of USD 33.7 billion by 2025, based on a new report by Grand View Research, Inc. Growing initiatives for development of drugs targeting novel cancer biomarkers coupled with the introduction of technologically advanced companion diagnostic kits is estimated to provide the market with high growth potential. Increasing awareness about personalized medicines amongst patients is further anticipated to boost adoption of cancer biomarkers.

In addition, presence of favorable government initiatives for the development of novel cancer diagnostic techniques is a key factor for market growth. For instance, the National Cancer Institute (NCI) provides funding to more than 8 research areas pertaining to cancer biomarker development. Cancer Research UK, Lung Cancer Research Foundation, and National Institutes of Health are some of the organizations providing funding for biomarker research.

People with high alcohol consumption, tobacco usage, unhealthy food habits, and sedentary lifestyle are reported to be 80% more at risk of developing cancer as compared to other individuals. Infections such as Human papillomavirus (HPV), Epstein-Barr virus, Hepatitis B virus, and Helicobacter pylori are also been studied to be related in cancer development.

Access Research Report of Cancer Biomarkers Market @ www.grandviewresearch.com/industry-analysis/cancer-biomarker-market

Further Key findings from the study suggest:

·       Breast cancer was the largest segment by revenue share in 2016 owing to high prevalence of this type of cancer

·       Lung cancer is estimated to be the fastest-growing type due to increasing research activities toward development of novel lung cancer biomarkers

·       Genetic biomarkers, being the highest used and easily detectable held the majority share of cancer biomarker market by biomolecule in 2016

·       However, epigenetic biomarkers are anticipated to witness lucrative growth due to increasing focus on finding the role of epigenetic modifications in cancer development

·       Cancer biomarkers are majorly used for diagnostic purpose owing to their high specificity

·       The personalized medicine segment is estimated to witness fastest CAGR of 15.0% over the forecast period

·       North America dominated in terms of revenue share in 2016 due to established R&D infrastructure and high acceptance of biomarker-based cancer testing in this region

·       Asia Pacific is anticipated to grow at a substantial growth rate till 2025 with CAGR of over 16.7%

·       Some of the major companies in the cancer biomarkers market are Abbott Laboratories; F.Hoffmann-La Roche Ltd.; QIAGEN; Thermo Fisher Scientific Inc.; Affymetrix Inc.; Illumina, Inc.; Agilent Technologies; Merck & Co. Inc.; Hologic, Inc.; Sino Biological Inc.; and Becton, Dickinson and Company

Grand View Research has segmented the cancer biomarkers market by type, biomolecule, applications, and region:

Cancer Biomarker Type Outlook (Revenue, USD Billion, 2014 - 2025)

·         Breast cancer

·         Prostate cancer

·         Colorectal cancer

·         Cervical cancer

·         Liver cancer

·         Lung cancer

·         Others

Cancer Biomarker Biomolecule Outlook (Revenue, USD Billion, 2014 - 2025)

·         Genetic Biomarkers

·         Epigenetic Biomarkers

·         Metabolic Biomarkers

·         Proteomic Biomarkers

·         Others

Cancer Biomarker Application Outlook (Revenue, USD Billion, 2014 - 2025)

·         Drug discovery and Development

·         Diagnostics

·         Personalized medicine

·         Others

Cancer Biomarker Regional Outlook (Revenue, USD Billion, 2014 - 2025)

·         North America

o    U.S.

o    Canada

·         Europe

o    Germany

o    UK

·         Asia Pacific

o    China

o    Japan

·         Latin America

o    Mexico

o    Brazil

·         MEA

o    South Africa

Access Press Release of Cancer Biomarkers Market@ www.grandviewresearch.com/press-release/global-cancer-biomarkers-market

About Grand View Research

Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: www.grandviewresearch.com